Machine learning methods have been used to accelerate the molecule optimization process. However, efficient search for optimized molecules satisfying several properties with scarce labeled data remains a challenge for machine learning molecule optimization. In this study, we propose MOMO, a multi-objective molecule optimization framework to address the challenge by combining learning of chemical knowledge with Pareto-based multi-objective evolutionary search. To learn chemistry, it employs a self-supervised codec to construct an implicit chemical space and acquire the continues representation of molecules. To explore the established chemical space, MOMO uses multi-objective evolution to comprehensively and efficiently search for similar molecules with multiple desirable properties. We demonstrate the high performance of MOMO on four multi-objective property and similarity optimization tasks, and illustrate the search capability of MOMO through case studies. Remarkably, our approach significantly outperforms previous approaches in optimizing three objectives simultaneously. The results show the optimization capability of MOMO, suggesting to improve the success rate of lead molecule optimization.
Infectious diseases continue to pose a serious threat to public health, underscoring the urgent need for effective computational approaches to screen novel anti-infective agents. Oligopeptides have emerged as promising candidates in antimicrobial research due to their structural simplicity, high bioavailability, and low susceptibility to resistance. Despite their potential, computational models specifically designed to predict associations between oligopeptides and infectious diseases remain scarce. This study introduces a prompt-guided graph-based contrastive learning framework (PGCLODA) to uncover potential associations. A tripartite graph is constructed with oligopeptides, microbes, and diseases as nodes, incorporating both structural and semantic information. To preserve critical regions during contrastive learning, a prompt-guided graph augmentation strategy is employed to generate meaningful paired views. A dual encoder architecture, integrating Graph Convolutional Network (GCN) and Transformer, is used to jointly capture local and global features. The fused embeddings are subsequently input into a multilayer perceptron (MLP) classifier for final prediction. Experimental results on a benchmark dataset indicate that PGCLODA consistently outperforms state-of-the-art models in AUROC, AUPRC, and accuracy. Ablation and hyperparameter studies confirm the contribution of each module. Case studies further validate the generalization ability of PGCLODA and its potential to uncover novel, biologically relevant associations. These findings offer valuable insights for mechanism-driven discovery and oligopeptide-based drug development. The source code of PGCLODA is available online at https://github.com/jjnlcode/PGCLODA.
In the field of multi-organ medical image segmentation, recent methods frequently employ Transformers to capture long-range dependencies from image features. However, these methods overlook the high computational cost of Transformers and their deficiencies in extracting local detailed information. To address high computational costs and inadequate local detail information, we reassess the design of feature extraction modules and propose a new deep-learning network called LamFormer for fine-grained segmentation tasks across multiple organs. LamFormer is a novel U-shaped network that employs Linear Attention Mamba (LAM) in an enhanced pyramid encoder to capture multi-scale long-range dependencies. We construct the Parallel Hierarchical Feature Aggregation (PHFA) module to aggregate features from different layers of the encoder, narrowing the semantic gap among features while filtering information. Finally, we design the Reduced Transformer (RT), which utilizes a distinct computational approach to globally model up-sampled features. RRT enhances the extraction of detailed local information and improves the network's capability to capture long-range dependencies. LamFormer outperforms existing segmentation methods on seven complex and diverse datasets, demonstrating exceptional performance. Moreover, the proposed network achieves a balance between model performance and model complexity.
Molecular optimization, which aims to discover improved molecules from a vast chemical search space, is a critical step in chemical development. Various artificial intelligence technologies have demonstrated high effectiveness and efficiency on molecular optimization tasks. However, few of these technologies focus on balancing property optimization with constraint satisfaction, making it difficult to obtain high-quality molecules that not only possess desirable properties but also meet various constraints. To address this issue, we propose a constrained multi-property molecular optimization framework (CMOMO), which is a flexible and efficient method to simultaneously optimize multiple molecular properties while satisfying several drug-like constraints. CMOMO improves multiple properties of molecules with constraints based on dynamic cooperative optimization, which dynamically handles the constraints across various scenarios. Besides, CMOMO evaluates multiple properties within discrete chemical spaces cooperatively with the evolution of molecules within an implicit molecular space to guide the evolutionary search. Experimental results show the superior performance of the proposed CMOMO over five state-of-the-art molecular optimization methods on two benchmark tasks of simultaneously optimizing multiple non-biological activity properties while satisfying two structural constraints. Furthermore, the practical applicability of CMOMO is verified on two practical tasks, where it identified a collection of candidate ligands of $β$2-adrenoceptor GPCR and candidate inhibitors of glycogen synthase kinase-3$β$ with high properties and under drug-like constraints.